Featured Research

from universities, journals, and other organizations

Expenditures for glaucoma medications appear to have increased

Date:
June 13, 2011
Source:
JAMA and Archives Journals
Summary:
In recent years, spending for glaucoma medications has increased, especially for women, persons who have only public health insurance and those with less than a high school education, according to a new study.

In recent years, spending for glaucoma medications has increased, especially for women, persons who have only public health insurance and those with less than a high school education, according to a report published Online First by Archives of Ophthalmology, one of the JAMA/Archives journals.

Glaucoma is a condition marked by damage to the optic nerve, and is a leading cause of blindness. According to background information in the article, approximately 2.2 million individuals ages 40 years and older in the United States currently have primary open-angle glaucoma; this number is expected to increase by almost 50 percent by 2020. Presently, the direct annual medical costs associated with the condition are roughly $2.9 billion. Although data on glaucoma-expense trends is limited, the authors note that "there is a direct correlation between increased expenditure and increased severity of glaucoma, with medication consisting of one-third to one-half of direct costs."

To study current trends in glaucoma-related medication expenditures, Byron L. Lam, M.D., from the Bascom Palmer Eye Institute in Miami, and colleagues examined data from the Medical Expenditure Panel Survey from 2001 to 2006. Beginning in 2006, these data included information about participation in the Medicare Part D prescription drug program. The analysis included 1,404 patients ages 18 years and older who had used glaucoma medication.

The authors found that in 2001, the average expenditure per patient for glaucoma medication was $445; by 2006, this amount had increased to $557. Significant increases appeared among women, those who had not completed high school and those who had only public health insurance. Additionally, average spending for prostaglandin analog medications increased from $168 in 2001 to $271 in 2006; during the same period, average spending for beta-blockers decreased from $167 to $69. In comparison with individuals who had private insurance, glaucoma medication expenditure among those with Medicare Part D coverage was higher.

The authors explain that as the country's population ages and encompasses more patients with glaucoma, spending for drugs to treat the condition is likely to increase. "The results of our study as well as an understanding of the factors that account for the increase in glaucoma medication expenditure are important to help develop effective strategies and protocols for the medical management of glaucoma that optimize treatment and control expenditures," they write. Further study to explain the trends among patient subgroups is needed, the authors conclude.


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Byron L. Lam; D. Diane Zheng; Evelyn P. Davila; Kristopher L. Arheart; Manuel A. Ocasio; Kathryn E. McCollister; Alberto J. Caban-Martinez; David J. Lee. Trends in Glaucoma Medication Expenditure: Medical Expenditure Panel Survey 2001-2006. Archives of Ophthalmology, 2011; DOI: 10.1001/archophthalmol.2011.142

Cite This Page:

JAMA and Archives Journals. "Expenditures for glaucoma medications appear to have increased." ScienceDaily. ScienceDaily, 13 June 2011. <www.sciencedaily.com/releases/2011/06/110613162059.htm>.
JAMA and Archives Journals. (2011, June 13). Expenditures for glaucoma medications appear to have increased. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2011/06/110613162059.htm
JAMA and Archives Journals. "Expenditures for glaucoma medications appear to have increased." ScienceDaily. www.sciencedaily.com/releases/2011/06/110613162059.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com
Lost Brain Cells To Blame For Sleep Problems Among Seniors

Lost Brain Cells To Blame For Sleep Problems Among Seniors

Newsy (Aug. 21, 2014) According to a new study, elderly people might have trouble sleeping because of the loss of a certain group of neurons in the brain. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins